Brian C Healy1, David Schoenfeld. 1. Biostatistics Center, Massachusetts General Hospital, 50 Staniford Street, Suite 560, Boston, Massachusetts 02114, USA. bchealy@partners.org
Abstract
INTRODUCTION: In this study we explore several methods for incorporating survival information in the analysis of Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) scores. METHODS: ALSFRS scores and patient survival times were simulated based on estimates from a recent clinical trial. Six analysis approaches were applied to the data. Each approach was based on ALSFRS scores, the survival time, or a combination of the 2. The power of each approach to detect potential treatment effects was estimated. RESULTS: When the treatment acted solely on the change in ALSFRS, the shared parameter model provided the most power, although all of the models based on random effects were similar. As the effect on survival increased, rank-based analysis showed potential gains in power. Survival analysis was superior under a small effect on ALSFRS and a larger effect on mortality. CONCLUSIONS: The shared parameter model and rank-based approach can offer improvements in power over traditional approaches.
INTRODUCTION: In this study we explore several methods for incorporating survival information in the analysis of Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) scores. METHODS: ALSFRS scores and patient survival times were simulated based on estimates from a recent clinical trial. Six analysis approaches were applied to the data. Each approach was based on ALSFRS scores, the survival time, or a combination of the 2. The power of each approach to detect potential treatment effects was estimated. RESULTS: When the treatment acted solely on the change in ALSFRS, the shared parameter model provided the most power, although all of the models based on random effects were similar. As the effect on survival increased, rank-based analysis showed potential gains in power. Survival analysis was superior under a small effect on ALSFRS and a larger effect on mortality. CONCLUSIONS: The shared parameter model and rank-based approach can offer improvements in power over traditional approaches.
Authors: Leonard H van den Berg; Stavros Nikolakopoulos; Ruben Pa van Eijk; Marinus Jc Eijkemans; Dimitris Rizopoulos Journal: Clin Epidemiol Date: 2018-03-19 Impact factor: 4.790
Authors: Fernando G Vieira; Subhashini Venugopalan; Alan S Premasiri; Maeve McNally; Aren Jansen; Kevin McCloskey; Michael P Brenner; Steven Perrin Journal: NPJ Digit Med Date: 2022-04-08
Authors: Ruben P A van Eijk; Kit C B Roes; Inez de Greef-van der Sandt; Leonard H van den Berg; Ying Lu Journal: Clin Pharmacol Ther Date: 2022-02-17 Impact factor: 6.903
Authors: Andrew McGarry; Michael McDermott; Karl Kieburtz; Elisabeth A de Blieck; Flint Beal; Karen Marder; Christopher Ross; Ira Shoulson; Peter Gilbert; William M Mallonee; Mark Guttman; Joanne Wojcieszek; Rajeev Kumar; Mark S LeDoux; Mary Jenkins; H Diana Rosas; Martha Nance; Kevin Biglan; Peter Como; Richard M Dubinsky; Kathleen M Shannon; Padraig O'Suilleabhain; Kelvin Chou; Francis Walker; Wayne Martin; Vicki L Wheelock; Elizabeth McCusker; Joseph Jankovic; Carlos Singer; Juan Sanchez-Ramos; Burton Scott; Oksana Suchowersky; Stewart A Factor; Donald S Higgins; Eric Molho; Fredy Revilla; John N Caviness; Joseph H Friedman; Joel S Perlmutter; Andrew Feigin; Karen Anderson; Ramon Rodriguez; Nikolaus R McFarland; Russell L Margolis; Eric S Farbman; Lynn A Raymond; Valerie Suski; Sandra Kostyk; Amy Colcher; Lauren Seeberger; Eric Epping; Sherali Esmail; Nancy Diaz; Wai Lun Alan Fung; Alan Diamond; Samuel Frank; Philip Hanna; Neal Hermanowicz; Leon S Dure; Merit Cudkowicz Journal: Neurology Date: 2016-12-02 Impact factor: 9.910
Authors: Eva L Feldman; Nicholas M Boulis; Junguk Hur; Karl Johe; Seward B Rutkove; Thais Federici; Meraida Polak; Jane Bordeau; Stacey A Sakowski; Jonathan D Glass Journal: Ann Neurol Date: 2014-03-07 Impact factor: 10.422